ClearLLab Control Cells -a liquid preparation of stabilized human erythrocytes and leukocytes (lymphocytes monocytes and granulocytes) - the first application-specific IVD control cells for L&L ...
Flow cytometry is an essential tool enabling precise cellular analysis across many fields, including immunology, oncology and cell biology research. However, suboptimal staining protocols can leave ...
The UAB Flow Cytometry Lab is home to a staff of medical laboratory professionals who perform complex testing using state-of-the-art flow cytometry equipment. This testing, through research, education ...
ANTIBODY TITRATION is critical to the success of any flow cytometry experiment. This is even more so in microflow cytometric analysis of extracellular vesicles (EVs), where removing excess antibodies ...
Analysis of gene expression in whole tissues using real-time RT-PCR, DNA microarrays and RNA sequencing provides insight into the state of cells in tissues under normal and pathological conditions.
One of the primary objectives for the application of flow cytometry in any testing environment should be measurement assurance, i.e., the generation of reliable and reproducible results. This goal can ...
Teaching of flow cytometry, histocompatibility, and immunology are combined into a one month rotation with the resident spending two weeks in flow cytometry, one week in the histocompatibility ...
Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...
A research team from George R Brown School of Engineering and Computing (Rice University; TX, USA), led by Peter Lillehoj and Kevin Mchugh, have developed an innovative AI-enabled microfluidic ...
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results